secwatch / observer

8-K filed February 28, 2025, 6:59 PM ET ticker RXRX CIK 0001601830

earnings confidence high sentiment neutral materiality 0.75

Recursion reports Q4 net loss $178.9M, FY2024 net loss $463.7M; cash runway into 2027

RECURSION PHARMACEUTICALS, INC.

2024-FY EPS reported -$1.69 revenue$58,839,000

Cash, cash equivalents and restricted cash $603.0M at Dec 31, 2024 vs $401.4M at Dec 31, 2023; runway extended into 2027.
Q4 revenue $4.5M (down 59% YoY); FY2024 revenue $58.8M (up 32% YoY). Pro forma revenue $82.6M.
Operating cash outflow $115.4M in Q4; $359.2M for FY2024. Exscientia cash burn ~$184M pre-acquisition.
Completed Exscientia merger Nov 2024; maintaining guidance of at least $100M in annual synergies.
Pipeline advanced: REC-617 showed durable partial response; three new clinical trials initiated (DAHLIA, TUPELO, ALDER).

item 2.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001601830-25-000034
form_type: 8-K
ticker: RXRX
cik: 0001601830
company_name: RECURSION PHARMACEUTICALS, INC.
filed_at: 2025-02-28T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.155181+00:00
generated_at: 2026-05-25T23:17:40.307731+00:00
sec_items: ["2.02", "7.01", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001601830-25-000034
json_url: https://secwatch.observer/filing/0001601830-25-000034.json
markdown_url: https://secwatch.observer/filing/0001601830-25-000034.md
text_url: https://secwatch.observer/filing/0001601830-25-000034.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000034/0001601830-25-000034-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000034/rxrx-20250228.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

FNGR

FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M

FingerMotion, Inc. May 29, 2026, 5:12 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

ADSK

Autodesk Q1 FY27 revenue up 18% to $1.93B, GAAP EPS $2.32; acquires MaintainX

Autodesk, Inc. May 28, 2026, 4:14 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

OKTA

Okta Q1 FY2027 rev $765M (+11% YoY); GAAP net income $74M; free cash flow $271M

Okta, Inc. May 28, 2026, 4:03 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

SOTK

Sono-Tek reports FY2026 net income up 42% to $1.8M; gross margin expands to 51%

SONO TEK CORP May 28, 2026, 7:10 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

DLTR

Dollar Tree Q1 net sales +7.2%, comp +3.5%, adj EPS $1.74 (+38%), raises FY guidance

DOLLAR TREE, INC. May 28, 2026, 6:31 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

BBWI

BBWI Q1 sales down 3%, adjusted EPS $0.32 beats guidance; CFO Boratto to step down June 12

Bath & Body Works, Inc. May 27, 2026, 7:12 AM ET earnings Items 2.02, 7.01, 5.02, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

SMTC

Semtech reports record Q1 net sales $291M, GAAP EPS $0.27, adjusted EPS $0.51

SEMTECH CORP May 26, 2026, 4:07 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

EMAT

EMAT reports Q1 GAAP net loss of $440.3M on $425M non-cash charge; adjusted loss $15.1M

Evolution Metals & Technologies Corp. May 22, 2026, 9:28 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001601830-25-000034

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.